|
1
|
Perez-Carbonell L, Balaguer F, Toiyama Y,
Egoavil C, Rojas E, Guarinos C, Andreu M, Llor X, Castells A, Jover
R, et al: IGFBP3 methylation is a novel diagnostic and predictive
biomarker in colorectal cancer. PLoS One. 9:e1042852014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carmona FJ, Azuara D, Berenguer-Llergo A,
Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R,
Villanueva A, Fraga MF, et al: DNA methylation biomarkers for
noninvasive diagnosis of colorectal cancer. Cancer Prev Res
(Phila). 6:656–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mahmodlou R, Mohammadi P and Sepehrvand N:
Colorectal cancer in northwestern Iran. ISRN Gastroenterol.
2012:9685602012.PubMed/NCBI
|
|
4
|
Wang X, Kuang YY and Hu XT: Advances in
epigenetic biomarker research in colorectal cancer. World J
Gastroenterol. 20:4276–4287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith RA, Cokkinides V and Eyre HJ:
American Cancer Society guidelines for the early detection of
cancer, 2006. CA Cancer J Clin. 56:11–25; quiz 49–50. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jenkinson F and Steele R: Colorectal
cancer screening-methodology. Surgeon. 8:164–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu H, Huang S, Zhang X, Wang D, Zhang X,
Yuan X, Zhang Q and Huang Z: DNA methylation analysis of SFRP2,
GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in
fecal DNA. Oncol Lett. 8:1751–1756. 2014.PubMed/NCBI
|
|
9
|
Grady WM and Carethers JM: Genomic and
epigenetic instability in colorectal cancer pathogenesis.
Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Timp W and Feinberg AP: Cancer as a
dysregulated epigenome allowing cellular growth advantage at the
expense of the host. Nat Rev Cancer. 13:497–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome-biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kondo Y and Issa JP: Epigenetic changes in
colorectal cancer. Cancer Metastasis Rev. 23:29–39. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ushijima T: Detection and interpretation
of altered methylation patterns in cancer cells. Nat Rev Cancer.
5:223–231. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Petko Z, Ghiassi M, Shuber A, Gorham J,
Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD
and Grady WM: Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon
polyps and in fecal DNA from patients with colorectal polyps. Clin
Cancer Res. 11:1203–1209. 2005.PubMed/NCBI
|
|
15
|
Draht MX, Riedl RR, Niessen H, Carvalho B,
Meijer GA, Herman JG, van Engeland M, Melotte V and Smits KM:
Promoter CpG island methylation markers in colorectal cancer: The
road ahead. Epigenomics. 4:179–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Estey MP, Kim MS and Trimble WS: Septins.
Curr Biol. 21:R384–R387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sandrock K, Bartsch I, Bläser S, Busse A,
Busse E and Zieger B: Characterization of human septin
interactions. Biol Chem. 392:751–761. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hall PA and Russell S: The pathobiology of
the septin gene family. J Pathol. 204:489–505. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wasserkort R, Kalmar A, Valcz G, Spisak S,
Krispin M, Toth K, Tulassay Z, Sledziewski AZ and Molnar B:
Aberrant septin 9 DNA methylation in colorectal cancer is
restricted to a single CpG island. BMC Cancer. 13:3982013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tóth K, Wasserkort R, Sipos F, Kalmár A,
Wichmann B, Leiszter K, Valcz G, Juhász M, Miheller P, Patai ÁV, et
al: Detection of methylated septin 9 in tissue and plasma of
colorectal patients with neoplasia and the relationship to the
amount of circulating cell-free DNA. PloS One. 9:e1154152014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kojima K, Sakai I, Hasegawa A, Niiya H,
Azuma T, Matsuo Y, Fujii N, Tanimoto M and Fujita S: FLJ10849, a
septin family gene, fuses MLL in a novel leukemia cell line CNLBC1
derived from chronic neutrophilic leukemia in transformation with
t(4; 11)(q21; q23). Leukemia. 18:998–1005. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Connolly D, Yang Z, Castaldi M, Simmons N,
Oktay MH, Coniglio S, Fazzari MJ, Verdier-Pinard P and Montagna C:
Septin 9 isoform expression, localization and epigenetic changes
during human and mouse breast cancer progression. Breast Cancer
Res. 13:R762011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Scott M, McCluggage WG, Hillan KJ, Hall PA
and Russell SE: Altered patterns of transcription of the septin
gene, SEPT9, in ovarian tumorigenesis. Int J Cancer. 118:1325–1329.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Burrows JF, Chanduloy S, McIlhatton MA,
Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG and
Russell SE: Altered expression of the septin gene, SEPT9, in
ovarian neoplasia. J Pathol. 201:581–588. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim DS, Hubbard SL, Peraud A, Salhia B,
Sakai K and Rutka JT: Analysis of mammalian septin expression in
human malignant brain tumors. Neoplasia. 6:168–178. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Church TR, Wandell M, Lofton-Day C, Mongin
SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T,
Osborn N, et al: Prospective evaluation of methylated SEPT9 in
plasma for detection of asymptomatic colorectal cancer. Gut.
63:317–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tóth K, Sipos F, Kalmár A, Patai ÁV,
Wichmann B, Stoehr R, Golcher H, Schellerer V, Tulassay Z and
Molnár B: Detection of methylated SEPT9 in plasma is a reliable
screening method for both left- and right-sided colon cancers. PLoS
One. 7:e460002012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tóth K, Galamb O, Spisák S, Wichmann B,
Sipos F, Valcz G, Leiszter K, Molnár B and Tulassay Z: The
influence of methylated septin 9 gene on RNA and protein level in
colorectal cancer. Pathol Oncol Res. 17:503–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tänzer M, Balluff B, Distler J, Hale K,
Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, Schuster T
and Ebert MP: Performance of epigenetic markers SEPT9 and ALX4 in
plasma for detection of colorectal precancerous lesions. PLoS One.
5:e90612010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Warren JD, Xiong W, Bunker AM, Vaughn CP,
Furtado LV, Roberts WL, Fang JC, Samowitz WS and Heichman KA:
Septin 9 methylated DNA is a sensitive and specific blood test for
colorectal cancer. BMC Med. 9:1332011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ahmed D, Danielsen SA, Aagesen TH,
Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A,
Lothe RA and Lind GE: A tissue-based comparative effectiveness
analysis of biomarkers for early detection of colorectal tumors.
Clin Transl Gastroenterol. 3:e272012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luther JA and Birren SJ: Neurotrophins and
target interactions in the development and regulation of
sympathetic neuron electrical and synaptic properties. Auton
Neurosci. 151:46–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakagawara A: Trk receptor tyrosine
kinases: A bridge between cancer and neural development. Cancer
Lett. 169:107–114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bouzas-Rodriguez J, Cabrera JR,
Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, Rousseau R,
Combaret V, Bénard J, Tauszig-Delamasure S and Mehlen P:
Neurotrophin-3 production promotes human neuroblastoma cell
survival by inhibiting TrkC-induced apoptosis. J Clin Invest.
120:850–858. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nikoletopoulou V, Lickert H, Frade JM,
Rencurel C, Giallonardo P, Zhang L, Bibel M and Barde YA:
Neurotrophin receptors TrkA and TrkC cause neuronal death whereas
TrkB does not. Nature. 467:59–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goldschneider D and Mehlen P: Dependence
receptors: A new paradigm in cell signaling and cancer therapy.
Oncogene. 29:1865–1882. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu X, Tahan SR, Pasha TL and Zhang PJ:
Expression of neurotrophin receptor Trk-C in nevi and melanomas. J
Cutan Pathol. 30:318–322. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Segal RA, Goumnerova LC, Kwon YK, Stiles
CD and Pomeroy SL: Expression of the neurotrophin receptor TrkC is
linked to a favorable outcome in medulloblastoma. Proc Natl Acad
Sci USA. 91:12867–12871. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bardelli A, Parsons DW, Silliman N, Ptak
J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler
KW, et al: Mutational analysis of the tyrosine kinome in colorectal
cancers. Science. 300:9492003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wood LD, Calhoun ES, Silliman N, Ptak J,
Szabo S, Powell SM, Riggins GJ, Wang TL, Yan H, Gazdar A, et al:
Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum
Mutat. 27:1060–1061. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Luo Y, Kaz AM, Kanngurn S, Welsch P,
Morris SM, Wang J, Lutterbaugh JD, Markowitz SD and Grady WM: NTRK3
is a potential tumor suppressor gene commonly inactivated by
epigenetic mechanisms in colorectal cancer. PLoS Genet.
9:e10035522013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
deVos T, Tetzner R, Model F, Weiss G,
Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C,
Habermann JK, et al: Circulating methylated SEPT9 DNA in plasma is
a biomarker for colorectal cancer. Clinical chemistry.
55:1337–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Su XL, Wang YF, Li SJ, Zhang F and Cui HW:
High methylation of the SEPT9 gene in Chinese colorectal cancer
patients. Genet Mol Res. 13:2513–2520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wasserkort R, Kalmar A, Valcz G, Spisak S,
Krispin M, Toth K, Tulassay Z, Sledziewski AZ and Molnar B:
Aberrant septin 9 DNA methylation in colorectal cancer is
restricted to a single CpG island. BMC Cancer. 13:3982013.
View Article : Google Scholar : PubMed/NCBI
|
